Decision Resources Group
260 Charles Street
16 articles with Decision Resources Group
Decision Resources Group announced Davis Walp has joined as Chief Strategy Officer.
Decision Resources Group (DRG) announced at the AMCP Managed Care and Specialty Pharmacy Annual Meeting the launch of Healthbase.
Decision Resources Group (DRG), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, has announced the launch of DRG Learning.
Decision Resources Group Release: A Focus on Specialty Pharmacy at Las Vegas Pharmaceutical Conference
Decision Resources Group Release: Keynote Speakers Announced for Sixth Annual Pinsonault Managed Markets Summit
Decision Resources Group Release: Competition for Early-Line Biologic Use Among Psoriasis Patients Intensifies as Humira Continues to Gain Ground on Enbrel
Decision Resources Group Release: Over the Next Decade, the Malignant Melanoma Drug Market Will Increase More Than Seven-Fold to $1.5 Billion in 2020
Decision Resources Group Release: Biosimilar Versions of TNF-alpha Inhibitors and Pegylated IFN-alpha Agents Will Save Healthcare Systems $5.3 Billion in 2020
Decision Resources, Inc. Finds Despite FDA Label Revisions Regarding LABA-Containing Drugs, Patient Share of LABA/ICS Combination Drugs Exceed Patient Share of Single-Agent ICS Drugs in Recently Treated Asthma Patients
Decision Resources, Inc. Release: The Majority of Surveyed U.S. Oncologists Identified FOLFIRINOX as the Most Efficacious Treatment for Advanced Pancreatic Cancer, When Compared to Other Currently Available Therapies
Decision Resources, Inc. Release: Virtually the Same Percentage of Surveyed Rheumatologists Selected Enbrel and Humira as the Most Efficacious Agent for the Treatment of Rheumatoid Arthritis
Decision Resources, Inc. Release: For the Treatment of Acute Heart Failure, the Highest Proportion of Surveyed Cardiologists Identify Furosemide as the Most Efficacious Agent, When Compared to Other Available Therapies